Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
finn-b-CD2_INSITU_CERVIX_UTERI_ENDOCERVIX | 2021 | Carcinoma in situ of cervix uteri, endocervix | NA | — | 16,379,784 |
finn-b-CD2_INSITU_CERVIX_UTERI_EXOCERVIX | 2021 | Carcinoma in situ of cervix uteri, exocervix | NA | — | 16,379,784 |
finn-b-CD2_INSITU_GENITAL | 2021 | Carcinoma in situ of other and unspecified genital organs | NA | — | 16,379,784 |
finn-b-CD2_INSITU_GENITAL_EXALLC | 2021 | Carcinoma in situ of other and unspecified genital organs (all cancers excluded) | NA | — | 16,378,985 |
finn-b-CD2_INSITU_SKIN | 2021 | Carcinoma in situ of skin | NA | — | 16,380,466 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: